CNS Pharmaceuticals, Inc. - CNSP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$651K
QoQ value delta ($000)
+$431K (+195.91%)
Implied price effect (QoQ)
-41.38%
Shares
Total shares
124,253
QoQ shares delta
+99,637 (+404.77%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CNSP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 11 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Stonepine Capital Management, LLC 256 48,827 0.19%
Ikarian Capital, LLC 240 45,830 0.02%
DRW Securities, LLC 81 15,429 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 71 13,524 0.0%
UBS Group AG 3 611 0.0%
BANK OF AMERICA CORP /DE/ 0 4 0.0%
DANSKE BANK A/S 0 1 0.0%
BARRETT & COMPANY, INC. 0 8 0.0%
MAI Capital Management 0 3 0.0%
Sound Income Strategies, LLC 0 16 0.0%